Progressive osseous heteroplasia resulting from a new mutation in the GNAS1 gene

Authors

  • I. Chan,

    1. Department of Dermatology, St Mary's Hospital, London, UK
    2. Genetic Skin Disease Group, St John's Institute of Dermatology, Division of Skin Sciences, Guy's, King's, and St Thomas' School of Medicine, St Thomas' Hospital, London, UK
    Search for more papers by this author
  • T. Hamada,

    1. Genetic Skin Disease Group, St John's Institute of Dermatology, Division of Skin Sciences, Guy's, King's, and St Thomas' School of Medicine, St Thomas' Hospital, London, UK
    2. Department of Dermatology, Kurume University School of Medicine, Kurume, Japan
    Search for more papers by this author
  • C. Hardman,

    1. Department of Dermatology, St Mary's Hospital, London, UK
    Search for more papers by this author
  • J. A. McGrath,

    1. Genetic Skin Disease Group, St John's Institute of Dermatology, Division of Skin Sciences, Guy's, King's, and St Thomas' School of Medicine, St Thomas' Hospital, London, UK
    Search for more papers by this author
  • F. J. Child

    1. Department of Dermatology, St Mary's Hospital, London, UK
    Search for more papers by this author

I. Chan, Genetic Skin Disease Group, St John's Institute of Dermatology, Division of Skin Sciences, Guy's, King's, and St Thomas' School of Medicine, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK. Tel.: +44 20 7928 9292 extn 3316.
E-mail: ien.chan@kcl.ac.uk

Summary

Progressive osseous heteroplasia (OMIM 166350) is a rare autosomal dominant condition that presents in childhood as dermal ossification and may progress deeper to involve subcutaneous fat and connective tissue. Recently, paternally inherited inactivating mutations in the GNAS1 gene on chromosome 20q13 have been implicated in the pathogenesis, although sporadic cases have also been reported. We report a 9-year-old British Chinese girl with progressive osseous heteroplasia resulting from a de novo missense mutation (W281R) in the GNAS1 gene. She is of small stature (0.4th centile) and started to develop skin lesions at the age of 9 months. These have been confirmed histologically as osteoma cutis. She is of normal intelligence and development and has no dysmorphic features. The GNAS1 gene exhibits imprinting and maternally inherited mutations have previously been shown to result in Albright's hereditary osteodystrophy (OMIM 103580) with pseudohypothyroidism type 1a, whereas paternally inherited mutations result in progressive osseous heteroplasia or the Albright's hereditary osteodystrophy phenotype with pseudopseudohypothyroidism (OMIM 300800). With only nine mutations of the GNAS1 gene reported so far in progressive osseous heteroplasia, this new mutation helps to extend further the genotype–phenotype correlation.

Ancillary